KLI

Login OAK 국가리포지터리

검색

Ulsan Univ. Repository

Browsing by 저자 : Daniel P Petrylak

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 6건 중 1-6 번을 표시중입니다.

1 Article Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. 이재련 ; Andre P Fay ; Andrea Necchi ; et al 2020
2 Article Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV-201): a multicentre, single-arm, phase 2 trial 이재련 ; Andrea Necchi ; Arjun V Balar ; et al 2021
3 Article Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma 이재련 ; Christof Vulsteke ; Chunzhang Wu ; et al 2021
4 Article Exposure-response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy Ronald de Wit ; Thomas Powles ; Daniel Castellano ; et al 2022
5 Article Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE) 이재련 ; Alexandra Drakaki ; Andrea Necchi ; et al 2020
6 Article Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials Joaquim Bellmunt ; Ronald de Wit ; Yves Fradet ; et al 2022

1

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.

Anonymous

Login

Guide